Glenmark Pharma Shares Soar 10%, Hit Upper Circuit On Massive $1.9B Licensing Deal With AbbVie For Cancer Drug
Glenmark Pharma share prices surged 10% after sealing a $700 million upfront global licensing deal with AbbVie for ISB 2001,…
